Argenx stock surged Monday after its blockbuster autoimmune drug, Vyvgart, showed promise in patients with inflammatory diseases. The post Argenx's Vyvgart Scored Another Win — Why Shares Bolted Higher appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real